Lymphokine-activated killer (LAK) therapy for advanced renal cell carcinoma : clinical study on arterial LAK therapy and experimental study on LAK cell activity

Experimental and clinical studies were conducted on lymphokine-activated killer (LAK) cell therapy for advanced renal cell carcinoma (RCC). The traffic assay using radiolabeled LAK cells indicated short-term but appreciable accumulation of LAK cells in the tumor site when trans-arterially infused. B...

Description complète

Détails bibliographiques
Publié dans:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 38(1992), 11 vom: 10. Nov., Seite 1311-8
Auteur principal: Hayakawa, M (Auteur)
Format: Article
Langue:Japanese
Publié: 1992
Accès à la collection:Hinyokika kiyo. Acta urologica Japonica
Sujets:English Abstract Journal Article Interleukin-2